Diagnostics antibodies and antigens for inflammatory bowel disease

Inflammatory bowel disease (IBD) is a group of idiopathic inflammatory disorders of the gastrointestinal (GI) tract characterized by the symptoms of abdominal pain and diarrhea. IBD is diagnosed by the comprehensive analysis of clinical findings, radiological imaging, invasive endoscopy and histopathological examination. Due to a lack of a gold standard, certain patients do not receive a definitive diagnosis using current Diagnostics criteria. Recently, the search for a noninvasive marker that could augment or replace part of this Diagnostics process has become a focus of IBD research. antibody markers, including microbial antibodies, autoantibodies and peptide antibodies, will minimize the use of endoscopic and radiologic examinations and improve the long-term prognosis of patients with IBD. Several intestinal inflammations and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

Genemedi supplies antibodies and antigens for Tinflammatory bowel disease testing for a wide selection of choices (please see below).

Classification: S100-A8